NO960041L - Hemoregulatoriske penta- eller heksapeptider - Google Patents
Hemoregulatoriske penta- eller heksapeptiderInfo
- Publication number
- NO960041L NO960041L NO960041A NO960041A NO960041L NO 960041 L NO960041 L NO 960041L NO 960041 A NO960041 A NO 960041A NO 960041 A NO960041 A NO 960041A NO 960041 L NO960041 L NO 960041L
- Authority
- NO
- Norway
- Prior art keywords
- hemoregulatory
- hexapeptides
- penta
- compounds
- myelopoietic
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 210000002798 bone marrow cell Anatomy 0.000 abstract 1
- 230000032823 cell division Effects 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 230000003525 myelopoietic effect Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Denne oppfinnelsen relaterer til peptidforbindelser som omfatter to monomere peptider med regulatorisk celleproliferings-aktivitet, knyttet sammen med to eller flere divalente brokoblingsenheter. Slike forbindelser har en stimulerende effekt på celledeling, spesielt for 1 myelopoese- og beinmargsceller.I. Peptidforbindelsene med regulatorsik celleproliferasjon aktivitet har formlene I. n eller III. hvor j A, og A,, som er like ete forskjeUige, representererI! hverkan uavhengig av hverandre være pyroglutaminsyre (p-Glu). picolinsyre (Pic), 3-hydroksypicolinsyre (30H-Pic). prolin. N-acetyl-prolin. pyrazinkarboksylsyre. pyrazindikarboksylsyre. nikotinsyre. isonikotinsyre. pipekolinsyre. pyrrolkarboksylsyre. antranilsyre. kinolinkarboksylsyre. isokinolinkarboksylsyre. turahkarboksylsyre, ortinsyre. eller pyraiolkarboksylsyre; 1 hver R» kan uavhengig av hverandre være «rin (Ser), gutaminsyre (Glu), \ uparagu«yre(Mp).treoiun(Trj)eneralloueordn(aThr); hver R' kan uavhengig være asparaginsyre (Mp), glutaminsyre (Glu), eller cystin(Cys); R' kan uavhengig være lysin (Lys), ortinin (Om) eller cystin (Cys); r og s kan begge være 0 eller 1; t og u kan begge være 0 eller 1 men minst en av t og u ml være 1; hver gruppe B representerer den bindende sidekjeden til Rog R' slik at (a) hver gruppe B kan uavhengig representere -(CHJ.-CONH-<CH)-, hvor v er 1 eller 2, og w er 3 eller 4, forutsatt at det i pepudkjeden hvor gruppe B er tilknyttet er RAsp eller Glu og R' er Lys eller Orn; eller (b) hver gruppe B kan uavhengig representere -CH,-S-S-CH,-, hvor Rog R' i peptidkjeden hvor gruppe B er tilknyttet, begge er Cys;. hver R kan uavhengig av hverandre være hydrogen eller metyl; og hver Rkan være en gruppe -OH eller NH„ og saltene derav.Søknaden omhandler også fremgangsmåte for fremstilling av de angitte forbindelser og mellomprodukter.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939314200A GB9314200D0 (en) | 1993-07-09 | 1993-07-09 | Peptide compounds |
| PCT/GB1994/001501 WO1995001990A1 (en) | 1993-07-09 | 1994-07-11 | Hemoregulatory penta- or hexapeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO960041L true NO960041L (no) | 1996-01-04 |
| NO960041D0 NO960041D0 (no) | 1996-01-04 |
Family
ID=10738530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO960041A NO960041D0 (no) | 1993-07-09 | 1996-01-04 | Hemoregulatoriske penta- eller heksapeptider |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0722459B1 (no) |
| JP (1) | JPH08512310A (no) |
| AT (1) | ATE174927T1 (no) |
| AU (1) | AU7129694A (no) |
| DE (1) | DE69415548D1 (no) |
| EE (1) | EE9400051A (no) |
| GB (1) | GB9314200D0 (no) |
| NO (1) | NO960041D0 (no) |
| WO (1) | WO1995001990A1 (no) |
| ZA (1) | ZA945006B (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9425730D0 (en) * | 1994-12-20 | 1995-02-22 | Nycomed Pharma As | Compounds |
| JP2010520238A (ja) | 2007-03-01 | 2010-06-10 | マリンクロット インコーポレイテッド | 統合された光活性低分子および統合された光活性低分子使用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8626539D0 (en) * | 1986-11-06 | 1986-12-10 | Nycomed As | Peptide compounds |
| ZW11290A1 (en) * | 1989-07-14 | 1990-10-31 | Smithkline Beecham Corp | Hemoregulatory peptides |
-
1993
- 1993-07-09 GB GB939314200A patent/GB9314200D0/en active Pending
-
1994
- 1994-07-11 AT AT94920544T patent/ATE174927T1/de not_active IP Right Cessation
- 1994-07-11 AU AU71296/94A patent/AU7129694A/en not_active Abandoned
- 1994-07-11 ZA ZA945006A patent/ZA945006B/xx unknown
- 1994-07-11 EE EE9400051A patent/EE9400051A/xx unknown
- 1994-07-11 EP EP94920544A patent/EP0722459B1/en not_active Expired - Lifetime
- 1994-07-11 JP JP7503935A patent/JPH08512310A/ja active Pending
- 1994-07-11 WO PCT/GB1994/001501 patent/WO1995001990A1/en not_active Ceased
- 1994-07-11 DE DE69415548T patent/DE69415548D1/de not_active Expired - Lifetime
-
1996
- 1996-01-04 NO NO960041A patent/NO960041D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA945006B (en) | 1995-02-21 |
| WO1995001990A1 (en) | 1995-01-19 |
| GB9314200D0 (en) | 1993-08-18 |
| ATE174927T1 (de) | 1999-01-15 |
| EE9400051A (et) | 1995-12-15 |
| EP0722459A1 (en) | 1996-07-24 |
| EP0722459B1 (en) | 1998-12-23 |
| AU7129694A (en) | 1995-02-06 |
| DE69415548D1 (de) | 1999-02-04 |
| JPH08512310A (ja) | 1996-12-24 |
| NO960041D0 (no) | 1996-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69738586D1 (de) | Hohe expressionsrate von proteinen | |
| TR199700610A2 (xx) | D���k molek�l a��rl�kl� ��z�n�r, t�m�r nekroz fakt�r� tip-I ve tip-II proteinleri. | |
| FI20010060A7 (fi) | 5-metoksi-indoli-3-karboksialdehydiamino-(pentyyliamino)metyleeni-hydratsoni | |
| ATE110743T1 (de) | Antikoagulierende peptide. | |
| DE3789413D1 (de) | Lymphokin-ähnliche Peptide. | |
| FI961044A0 (fi) | Kininogeeni-inhibiittorit | |
| EP0644769A4 (en) | BIOLOGICALLY ACTIVE PEPTIDES WITH N-TERMINAL SUBSTITUTIONS. | |
| MY104909A (en) | Peptide compounds. | |
| NO960041L (no) | Hemoregulatoriske penta- eller heksapeptider | |
| EP0372503A3 (en) | Anticoagulant peptides | |
| DE69427363D1 (de) | Plättchenaggregationsinhibierende peptide | |
| GR3021660T3 (en) | Anticoagulant peptides | |
| ATE172204T1 (de) | Doppelsträngige peptidverbindungen mit hämoregulatorischer aktivität | |
| DK0938555T3 (da) | Konstruktioner og komplekser af cyclin E | |
| DE3869939D1 (de) | Biologisch wirksame peptide. | |
| NO944668L (no) | Dobbeltkjedete peptidforbindelser med hemoregulatorisk aktivitet | |
| DE69420044D1 (de) | Blutregulierende peptide | |
| NO962204D0 (no) | Dobbeltkjedede hemoregulatoriske peptider | |
| MA21633A1 (fr) | Sunthese peptidiques en phase solide. | |
| DE68914057D1 (de) | Peptide. | |
| ATE96806T1 (de) | Peptide mit laminin-wirksamkeit. | |
| ATE103339T1 (de) | Lymphokin-aehnliche peptide. | |
| ATE81531T1 (de) | Biologisch aktive peptide tan-866. |